Created at	Source	Raw Value	Validated value
Feb. 3, 2023, 8 p.m.	usa	Phase III - Increase in titres of neutralizing anti SARS-CoV-2 IgG antibodies in serum;Phase II - Increase in titres of neutralizing anti SARS-CoV-2 IgG antibodies in serum;Phase II - T-cell elicited responses	Phase III - Increase in titres of neutralizing anti SARS-CoV-2 IgG antibodies in serum;Phase II - Increase in titres of neutralizing anti SARS-CoV-2 IgG antibodies in serum;Phase II - T-cell elicited responses